Russia attacked one of Ukraine's largest pharmaceutical plants
On October 7, Russian troops struck the Borshchahivka Chemical-Pharmaceutical Plant (BCPP) in Kyiv, which is among the largest medicine producers in Ukraine. This is another attack on the pharmaceutical industry after a series of strikes on medicine factories and warehouses in August-October.
According to a source of "Ekonomichna Pravda" on the pharmaceutical market, the hit on the enterprise occurred on October 7 at approximately 17:00.
The source did not provide details on the scale of destruction and material losses. There is also no confirmed information yet about a possible suspension of production or the impact of the attack on medicine supplies.
Borshchahivka CPP is the seventh largest pharmaceutical manufacturer in Ukraine by revenue, according to Forbes Ukraine rating. The enterprise has been operating since 1947 and produces about 125 names of medicines.
At the end of 2025, the plant's net profit grew by 3% to 281.8 million UAH. The value of produced pharmaceutical products reached 2.48 billion UAH. The total volume of sales of finished products and goods was 43.8 million packages.
The enterprise also operates in 24 international markets, including countries of Eastern Europe, Asia and Australia.
Until 1994, Borshchahivka plant was part of the pharmaceutical producer "Darnitsa", but after privatization it became a joint Ukrainian-American enterprise. Later, "Darnitsa" returned to the shareholders and as of 2026 owns approximately 31.8% of BCPP shares.
The strike on Borshchahivka plant became another case of damage to Ukrainian pharmaceutical infrastructure in recent months. In particular, on October 4, as a result of a Russian attack, the pharmaceutical enterprise "Kusum" in Sumy was destroyed.
In September, Russian troops repeatedly attacked the plant of "Darnitsa" company in Kyiv. Large pharmaceutical warehouses and logistics complexes also came under fire.
In particular, on September 3, significant damage was inflicted on the logistics complex of "HFC Biocon" in Kyiv region, where medicines of various producers were stored. On the same day, warehouses of the pharmaceutical company "Teva Ukraine" and the chain "Apteka Dobroho Dnya" were attacked. The latter reported the destruction of hundreds of tons of medicines intended for supply to pharmacies across Ukraine.
In September, warehouse facilities of large pharmaceutical distributors BaDM and "Optima-Pharm" were also damaged, and on October 2, the warehouse of "Venta LTD" company in Hostomel was hit by a Russian strike.
Damage to pharmaceutical warehouses has already affected the availability of certain drugs in Ukraine. According to the Ministry of Health, in August-September, temporary disruptions in the availability of medicines occurred in some regions. Among the reasons are destruction of warehouse infrastructure, logistics disruptions, uneven supply of imported drugs and increased demand.
In particular, problems were observed with the availability of drugs based on levothyroxine sodium — "Euthyrox" and "L-Thyroxine". After arrival of additional batches, the situation stabilized.
At the same time, the Ministry of Health emphasized that as of early October, there were no signs of systemic shortage of medicines in Ukraine. Despite infrastructure damage, distributors continued supplies, rebuilding logistics routes and using alternative storage locations for medicines.
The ministry warned that further Russian shelling could affect the availability of certain drugs depending on the region. The consequences of the latest strike on Borshchahivka CPP for the Ukrainian pharmaceutical market are yet to be assessed.
Based on materials: "Ekonomichna Pravda", Forbes Ukraine, hromadske
